Carbon Reduction Plan

Supplier name: Lloyds Clinical Limited

Publication date: 16/10/2026

Commitment to Achieving Net Zero

Lloyds Clinical is committed to achieving Net Zero emissions in scope 1 and 2 by 2040 and absolute emissions by 2045, 5 years ahead of the Governments own Net Zero commitment of 2050. The emissions calculated and actions implements in this Carbon Reduction Plan are for Lloyds Clinical’s UK operations only.

Baseline Emissions Footprint

Baseline emissions are a record of the greenhouse gases that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions.
Baseline emissions are the reference point against which emissions reduction can be measured.

This Carbon Reduction Plan is the first which Lloyds Clinical has completed and will therefore act as both the current emissions reporting and the baseline year. There have been no previous emission calculations.

Full report can be found here.

Emissions Reduction Targets 

In order to continue our progress to achieving net zero, we have adopted the following carbon reduction targets.

• 20% reduction in absolute emissions by 2030 from 2026 baseline year. This is made up of reductions in the below groups of scopes:
o Scope 1 and 2: 29%
o Scope 3: 7%

• 46% reduction in absolute emissions by 2035 from 2026 baseline year. This is made up of reductions in the below groups of scopes:
o Scope 1 and 2: 57%
o Scope 3: 29%

• 80% reduction in absolute emissions by 2040 from 2026 baseline year. This is made up of reductions in the below groups of scopes:
o Scope 1 and 2: 90%
o Scope 3: 80%

• 94% reduction in absolute emissions by 2045 from 2026 baseline year. This is made up of reductions in the below groups of scopes:
o Scope 1 and 2: 96%
o Scope 3: 90%

Lloyds Clinical will focus on reducing our emissions as much as possible however, we realise that there will be emissions that we cannot avoid. We therefore plan to utilise offsets to abate these emissions on our journey to Net Zero. The graph above shows the absolute emissions reduction that we plan to make.

Carbon Reduction Projects

Completed carbon reduction initiatives

Given that this is the first reporting year, Lloyds Clinical are unable to document impact from initiatives which have been implemented since the beginning of our reporting against PPN006.

Future carbon reduction initiatives

In the future we hope to implement further measures to help us on our path to Net Zero.

Scope 1 and 2: Stationary combustion, Transport, Refrigerants and Electricity
Our emissions for scope 1 and 2 are primarily from Transportation (42.3% of total emissions) and Electricity (11.5% of total emissions) where we have control. In the near-term future, we will
• Replace our brown supply electricity with verified renewable sources
• Work towards creating a fleet transition to hybrid and electric vehicles where appropriate

Scope 3:
Of our total emissions, 20.5% sit within Category 7: Employee commuting, 8.4% is attributed to Upstream Transportation and distribution and 3.1% from Business Travel. Our Primary focus for Scope 3 will be to:
• Improve data collection across all categories to reduce or remove the reliance on spend-based calculations
• Complete an employee commuting survey
• Implement a business travel hierarchy as an addition to our environmental and sustainability policy released in 2025.
• Obtain freight data for Category 4

Declaration and Sign Off

This Carbon Reduction Plan has been completed in accordance with PPN 006 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard13 and use the appropriate government emission conversion factors for greenhouse gas company reporting.14
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements (where required), and the required subset of Scope 3 emissions has been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.15
This Carbon Reduction Plan has been reviewed and signed off by the board of directors (or equivalent management body).

 

Statement of approval

This Statement has been approved by the Board of Directors of Lloyds Clinical Limited, and the Board has authorised Sean Feeney Chief Executive Officer, to sign the Statement on behalf of Lloyds Clinical Limited.
Date: 16 October 2026

 

Full report can be found here.

 

13 https://ghgprotocol.org/corporate-standard
14 www.gov.uk/government/collections/government-conversion-factors-for-company-reporting
15 https://ghgprotocol.org/standards/scope-3-standard